Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
Clinical trial NCT02568683 · TERMINATED
Trial details
- NCT number
- NCT02568683
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-11
- Primary completion
- 2016-10-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.